Information  X 
Enter a valid email address
  Print          More announcements

Thursday 17 October, 2019

Vanguard Funds PLC

Dividend Notification

RNS Number : 2810Q
Vanguard Funds PLC
17 October 2019
 

 

STOCK EXCHANGE ANNOUNCEMENT

 

For Immediate Release                                                                       17th October 2019

 

Vanguard Funds plc.

 

Re:  Dividend Payment

 

The Directors of Vanguard Funds plc. (the "Company") wish to announce that dividends for the month of October 2019 were issued for the following sub-funds:

 

Sub-Fund

Record Date

Payment Date

Amount per Share

Vanguard UK Gilt UCITS ETF - (GBP) Distributing (ISIN: IE00B42WWV65)

25.10.2019

06.11.2019

£0.025087

Vanguard EUR Corporate Bond UCITS ETF - (EUR) Distributing (ISIN: IE00BZ163G84)

25.10.2019

06.11.2019

€0.026821

Vanguard EUR Eurozone Government Bond UCITS ETF - (EUR) Distributing (ISIN: IE00BZ163H91)

25.10.2019

06.11.2019

€0.007707

Vanguard USD Corporate Bond UCITS ETF - (USD) Distributing (ISIN: IE00BZ163K21)

25.10.2019

06.11.2019

$0.144324

Vanguard USD Treasury Bond UCITS ETF - (USD) Distributing (ISIN: IE00BZ163M45)

25.10.2019

06.11.2019

$0.043594

Vanguard USD Emerging Markets Government Bond UCITS ETF - (USD) Distributing (ISIN: IE00BZ163L38)

25.10.2019

06.11.2019

$0.179780

Vanguard Global Aggregate Bond UCITS ETF - (GBP) Distributing (ISIN: IE00BG47KG48)

25.10.2019

06.11.2019

£0.022883

Vanguard Global Aggregate Bond UCITS ETF - (EUR) Distributing (ISIN: IE00BG47KB92)

25.10.2019

06.11.2019

€0.022662

Vanguard USD Corporate 1-3 Year Bond UCITS ETF - (USD) Distributing (ISIN: IE00BDD48R20)

25.10.2019

06.11.2019

$0.104596

 

 

Enquiries to;

 

J & E Davy

Paul Boland

+353 1 614 3378

 

 

 

 

 

 

 

 

This announcement has been issued through the Companies Announcement Service of Euronext Dublin.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEEADEXFLDNFFF

a d v e r t i s e m e n t